Latest China Cord Blood Corporation. (CO) Headline
Post# of 30
Posted On: 03/14/2014 1:01:41 PM
Latest China Cord Blood Corporation. (CO) Headlines
Almost Family (AFAM) in Focus: Stock Tumbles 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:40AM CDT
Shares of Almost Family fell nearly 10% last session and also witnessed continuous downtrend in the past one-month time frame over 14%. So its time to keep a close watch on this firm in the near future and especially on earnings estimates following the recent slump.
Quest Diagnostics to Buy Summit Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 4:00PM CDT
Post acquisition, Summit Health's services will complement the health and wellness business of Quest Diagnostics.
Gentiva Ratings Outlook Slashed on Weak Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 3:40PM CDT
Moody's Investors service has recently downgraded the rating outlook on Gentiva Health Services to negative from stable.
Weakness Seen in Gentiva Health Services (GTIV) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:35AM CST
Gentiva has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
Gentiva (GTIV) in Focus: Stock Tumbles 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:36AM CST
The shares of Gentiva fell over 10% on the day. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $10.3 to $11.1 in the past one-month time frame. This home health services provider company has seen a flat track record when it comes to current year estimate revisions.
Chemed Corp. (CHE) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:45AM CST
Chemed Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy
Select Bancorp Reports 2013 Earnings
PR Newswire - Wed Feb 26, 7:26AM CST
For the year ended December 31, 2013, Select Bancorp ("Select"), the holding company for Select Bank & Trust Company, reported net income of $2.5 million, or fully diluted earnings per share of $0.99, compared to net income of $2.0 million, or fully diluted earnings per share of $0.81, for the twelve months ended December 31, 2012.
China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2014 Financial Results
PR Newswire - Mon Feb 17, 7:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the third quarter and first nine months of fiscal year 2014 on Monday, February 24, 2014, after the markets close in the U.S.
DaVita Healthcare Beats on Q4 Earnings & Revs, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 12, 10:20AM CST
DaVita HealthCare reported fourth-quarter 2013 net operating earnings of 99 cents per share, beating the Zacks Consensus Estimate by a penny
Wheels Roll in Transportation, 3 Stocks Set to Beat Q4 Earnings - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 11:02AM CST
Overall, the sector is expected to register a double-digit (17%)earnings improvement.
Almost Family (AFAM) Soars: Stock Up 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 10, 8:39AM CST
Almost Family Inc. was a big mover last session, as its shares rose almost 8% on the day.
Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Jan 07, 3:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/6hn8s3/cord_blood) has announced the addition of the "Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Cord blood can be stored in two ways, banking in private cord blood banks or donating in public cord blood banks. Private cord blood banks collect and store cord blood for the use of baby and close family members only. Collection and storage of the cord blood is charged to the parents of the baby. The cord blood can aldso be donated to a public bank where the cord blood unit is stored and is publicly available for the suitable match. All the charges of storage and maintenance of the cord blood unit obtained from public bank are taken from the patient or patient's family for whom the unit is going to utilize in transplantation process. Though globally the number of private cord blood banks are more as compared to public banks, number of units stored in public banks are more than units of cord blood banks stored in private banks globally. The amount of stem cells required for the transplantation process vary depending on person's weight and age. The major disadvantage of cord blood storing in private cord blood bank is that the single unit of the cord blood contains insufficient amount of stem cells and becomes difficult to treat adults using stem cell transplant. On the other hand, cord blood units stored in public banks is available to any patient matching with the blood unit sample stored in public banks globally. And hence multiple units can be utilized for single patient to meet the requirement of the stem cells in transplantation procedure. Taking inability of the privately stored cord blood units to meet the requirement of the amount of stem cell into consideration healthcare professionals are focusing on enhancing cord blood inventory in public banks so that demand for the cord blood units can be matched. Gynecologists, pediatricians and obstetricians recommend to store cord blood in private banks only if the family has history of the disease that can be treated using stem cells. Key Topics Covered - Introduction - Executive Summary - Global Cord Blood Banking Services Market Overview - Global Cord Blood Banking Services Market, by Storage Options, 2011 - 2019 (USD Billion) - Global Cord Blood Banking Services Market, by Geography, Size and Forecast, 2011 - 2019 (USD Billion) - Recommendations - Company Profiles Companies Mentioned - China Cord Blood Corporation - Cord Blood America - Cord Blood Registry Systems - Cordlife Group - Cryo-Cell International - Cryo-Save Group - NeoStem - ViaCord For more information visit http://www.researchandmarkets.com/research/6hn8s3/cord_blood About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
China Cord Blood Corporation Announces Results of 2013 Annual General Meeting
PR Newswire - Mon Dec 16, 3:05PM CST
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2013 Annual General Meeting, which was held on December 16, 2013, in Hong Kong.
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2014
PR Newswire - Thu Nov 14, 3:05PM CST
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the second quarter and first half of fiscal year 2014, which ended September 30, 2013.
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2014 Financial Results
PR Newswire - Thu Nov 07, 5:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the second quarter and first half of fiscal year 2014 on Thursday, November 14, 2013, after market close in the US.
5 Stocks Under $10 to Trade for Breakouts
at The Street - Fri Nov 01, 8:06AM CDT
OTC Daily Alert Stock Watch - China Cord Blood Corporation. (NYSE: CO)
WorldStockWire - Mon Sep 02, 11:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2014
PR Newswire - Mon Aug 26, 3:01PM CDT
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the first quarter of fiscal year 2014 ended June 30, 2013.
China Cord Blood Corporation to Report First Quarter of Fiscal 2014 Financial Results
PR Newswire - Tue Aug 20, 6:00AM CDT
China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the first quarter of fiscal year 2014 on Monday, August 26, 2013, after market close in the U.S.
Weak Q2 Earnings for Gentiva, View Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 01, 8:29AM CDT
Gentiva reported second-quarter 2013 operating earnings of 22 cents per share, which surpassed the Zacks Consensus Estimate of 20 cents.
Almost Family (AFAM) in Focus: Stock Tumbles 9.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 7:40AM CDT
Shares of Almost Family fell nearly 10% last session and also witnessed continuous downtrend in the past one-month time frame over 14%. So its time to keep a close watch on this firm in the near future and especially on earnings estimates following the recent slump.
Quest Diagnostics to Buy Summit Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 4:00PM CDT
Post acquisition, Summit Health's services will complement the health and wellness business of Quest Diagnostics.
Gentiva Ratings Outlook Slashed on Weak Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 12, 3:40PM CDT
Moody's Investors service has recently downgraded the rating outlook on Gentiva Health Services to negative from stable.
Weakness Seen in Gentiva Health Services (GTIV) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 7:35AM CST
Gentiva has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
Gentiva (GTIV) in Focus: Stock Tumbles 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 7:36AM CST
The shares of Gentiva fell over 10% on the day. This breaks the recent trend of the company, as the stock is now trading below the volatile price range of $10.3 to $11.1 in the past one-month time frame. This home health services provider company has seen a flat track record when it comes to current year estimate revisions.
Chemed Corp. (CHE) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 7:45AM CST
Chemed Corp. has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy
Select Bancorp Reports 2013 Earnings
PR Newswire - Wed Feb 26, 7:26AM CST
For the year ended December 31, 2013, Select Bancorp ("Select"), the holding company for Select Bank & Trust Company, reported net income of $2.5 million, or fully diluted earnings per share of $0.99, compared to net income of $2.0 million, or fully diluted earnings per share of $0.81, for the twelve months ended December 31, 2012.
China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2014 Financial Results
PR Newswire - Mon Feb 17, 7:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the third quarter and first nine months of fiscal year 2014 on Monday, February 24, 2014, after the markets close in the U.S.
DaVita Healthcare Beats on Q4 Earnings & Revs, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 12, 10:20AM CST
DaVita HealthCare reported fourth-quarter 2013 net operating earnings of 99 cents per share, beating the Zacks Consensus Estimate by a penny
Wheels Roll in Transportation, 3 Stocks Set to Beat Q4 Earnings - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 11:02AM CST
Overall, the sector is expected to register a double-digit (17%)earnings improvement.
Almost Family (AFAM) Soars: Stock Up 7.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 10, 8:39AM CST
Almost Family Inc. was a big mover last session, as its shares rose almost 8% on the day.
Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Tue Jan 07, 3:04AM CST
Research and Markets (http://www.researchandmarkets.com/research/6hn8s3/cord_blood) has announced the addition of the "Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Cord blood can be stored in two ways, banking in private cord blood banks or donating in public cord blood banks. Private cord blood banks collect and store cord blood for the use of baby and close family members only. Collection and storage of the cord blood is charged to the parents of the baby. The cord blood can aldso be donated to a public bank where the cord blood unit is stored and is publicly available for the suitable match. All the charges of storage and maintenance of the cord blood unit obtained from public bank are taken from the patient or patient's family for whom the unit is going to utilize in transplantation process. Though globally the number of private cord blood banks are more as compared to public banks, number of units stored in public banks are more than units of cord blood banks stored in private banks globally. The amount of stem cells required for the transplantation process vary depending on person's weight and age. The major disadvantage of cord blood storing in private cord blood bank is that the single unit of the cord blood contains insufficient amount of stem cells and becomes difficult to treat adults using stem cell transplant. On the other hand, cord blood units stored in public banks is available to any patient matching with the blood unit sample stored in public banks globally. And hence multiple units can be utilized for single patient to meet the requirement of the stem cells in transplantation procedure. Taking inability of the privately stored cord blood units to meet the requirement of the amount of stem cell into consideration healthcare professionals are focusing on enhancing cord blood inventory in public banks so that demand for the cord blood units can be matched. Gynecologists, pediatricians and obstetricians recommend to store cord blood in private banks only if the family has history of the disease that can be treated using stem cells. Key Topics Covered - Introduction - Executive Summary - Global Cord Blood Banking Services Market Overview - Global Cord Blood Banking Services Market, by Storage Options, 2011 - 2019 (USD Billion) - Global Cord Blood Banking Services Market, by Geography, Size and Forecast, 2011 - 2019 (USD Billion) - Recommendations - Company Profiles Companies Mentioned - China Cord Blood Corporation - Cord Blood America - Cord Blood Registry Systems - Cordlife Group - Cryo-Cell International - Cryo-Save Group - NeoStem - ViaCord For more information visit http://www.researchandmarkets.com/research/6hn8s3/cord_blood About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
China Cord Blood Corporation Announces Results of 2013 Annual General Meeting
PR Newswire - Mon Dec 16, 3:05PM CST
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2013 Annual General Meeting, which was held on December 16, 2013, in Hong Kong.
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2014
PR Newswire - Thu Nov 14, 3:05PM CST
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the second quarter and first half of fiscal year 2014, which ended September 30, 2013.
China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2014 Financial Results
PR Newswire - Thu Nov 07, 5:00AM CST
China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the second quarter and first half of fiscal year 2014 on Thursday, November 14, 2013, after market close in the US.
5 Stocks Under $10 to Trade for Breakouts
at The Street - Fri Nov 01, 8:06AM CDT
OTC Daily Alert Stock Watch - China Cord Blood Corporation. (NYSE: CO)
WorldStockWire - Mon Sep 02, 11:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2014
PR Newswire - Mon Aug 26, 3:01PM CDT
China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the first quarter of fiscal year 2014 ended June 30, 2013.
China Cord Blood Corporation to Report First Quarter of Fiscal 2014 Financial Results
PR Newswire - Tue Aug 20, 6:00AM CDT
China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the first quarter of fiscal year 2014 on Monday, August 26, 2013, after market close in the U.S.
Weak Q2 Earnings for Gentiva, View Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 01, 8:29AM CDT
Gentiva reported second-quarter 2013 operating earnings of 22 cents per share, which surpassed the Zacks Consensus Estimate of 20 cents.
(0)
(0)China Cord Blood Corporation. (CO) Stock Research Links
Scroll down for more posts ▼